Keywords: fda, accepts, snda, gsk, hycamtin, uk, drug

FDA accepts sNDA on GSK's Hycamtin

Article | 27 February 2006

Print This

UK drug major GlaxoSmithKline says that its supplemental New Drug Application submitted to the US Food and Drug Administration on ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in